IMPLANTABLE DEVICES, AND METHODS FOR USE THEREWITH, FOR PERFORMING CARDIAC AND AUTONOMIC ASSESSMENTS USING PHASE RECTIFIED SIGNAL AVERAGING

Patent №

US 7,512,439

Granted

2009-03-31

Filed 2005

Owner

PACESETTER, INC.

Lab

AI components

2

kr · hardware

Assignment

Recorded

Dataset

AIPD

2023_r1 edition

Application

11249653

Provided herein are implantable devices, and methods for use therewith, that perform at least one of a cardiac assessment and an autonomic assessment. An implantable device is used to sense a cardiac electrogram (EGM) signal, and cardiac intervals are measured within a portion of the sensed EGM signal. Anchor points are identified based on the measured cardiac intervals, and for each identified anchor point, a segment of at least three consecutive said cardiac intervals that is generally centered about the anchor point is defined. The segments defined for the anchor points are averaged to produce an average segment. At least one of a cardiac assessment and an autonomic assessment is performed based on the average segment. This can include assessing a patient's autonomic tone based on the average segment, assessing a patients risk of SCD based on the average segment and/or detecting a myocardial ischemic event based on the average segment. This abstract is not intended to describe all of the various embodiments of the present invention.

Knowledge representationAI hardwareA61B 5/364A61B 5/349A61B 5/366A61B 5/4035A61B 5/7275A61B 5/7282G16H 20/10G16H 20/40+5 more

AI classification

AI hardware0.99
Knowledge representation0.94
Planning0.02
Vision0.01
Natural language0.00
Evolutionary computation0.00
Machine learning0.00
Speech0.00

Ownership

PACESETTER, INC.

assignment · 171030986

Assignors

FARAZI, TARANEH

On an employer assignment, the assignors are typically the inventors.

From the same owner

© 2026 NYSGPT2525 LLC